MeiraGTx Holdings (MGTX) Cash from Financing Activities (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Cash from Financing Activities of $5.3 million for Q4 2025, up 2532.88% on a QoQ basis from -$219000.0 in Q3 2025, and up 25.54% year-over-year from $4.2 million in Q4 2024.
MeiraGTx Holdings (MGTX) Cash from Financing Activities (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Cash from Financing Activities history runs 9 years deep, the most recent figure standing at $5.3 million for Q4 2025.
- Quarterly Cash from Financing Activities rose 25.54% year-over-year to $5.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.3 million (down 77.5% YoY) and the FY2025 annual result came in at $12.3 million, down 77.5% from the prior year.
- Cash from Financing Activities was $5.3 million for Q4 2025 at MeiraGTx Holdings, up from -$219000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $72.9 million in Q3 2022 and bottomed at -$2.6 million in Q1 2022.
- A 5-year average of $13.0 million and a median of $1.6 million in 2024 frame the typical range for Cash from Financing Activities.
- Peak annual rise in Cash from Financing Activities reached 134990.74% in 2022, while the deepest fall reached 1998.53% in 2022.
- MeiraGTx Holdings' Cash from Financing Activities stood at $1.3 million in 2021, then jumped by 1817.61% to $24.8 million in 2022, then gained by 11.59% to $27.7 million in 2023, then plunged by 84.68% to $4.2 million in 2024, then climbed by 25.54% to $5.3 million in 2025.
- Business Quant data shows MGTX's Cash from Financing Activities at $5.3 million in Q4 2025, -$219000.0 in Q3 2025, and $5.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 68.63 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 9,311.16 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 238.74 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.33 Mn |
| Dec 31, 2025 | 5.33 Mn |
| Sep 30, 2025 | -219,000.00 |
| Sep 30, 2025 | -219,000.00 |
| Jun 30, 2025 | 5.45 Mn |
| Jun 30, 2025 | 5.45 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 4.24 Mn |
| Dec 31, 2024 | 4.24 Mn |
| Sep 30, 2024 | 49.96 Mn |
| Sep 30, 2024 | 49.96 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | -1.27 Mn |
| Mar 31, 2024 | -1.27 Mn |
| Dec 31, 2023 | 27.71 Mn |
| Dec 31, 2023 | 27.71 Mn |
| Sep 30, 2023 | -404,000.00 |
| Sep 30, 2023 | -404,000.00 |